Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,090 | -10,711 | -10,628 | -10,320 | N/A |
| Depreciation Amortization | 36 | 27 | 24 | 20 | N/A |
| Accounts payable and accrued liabilities | 153 | -770 | 1,337 | N/A | N/A |
| Other Working Capital | 2,571 | -3,356 | 1,047 | 450 | N/A |
| Other Operating Activity | 504 | 2,581 | -216 | 3,060 | 0 |
| Operating Cash Flow | $-17,826 | $-12,229 | $-8,436 | $-6,790 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,500 | -7,000 | 477 | N/A | N/A |
| PPE Investments | -14 | -70 | -14 | -8 | N/A |
| Sale Of Investment | N/A | 243 | 876 | N/A | N/A |
| Purchase Sale Intangibles | -1,620 | -1,035 | -210 | N/A | N/A |
| Other Investing Activity | 8,322 | -11,035 | -210 | 2,978 | 0 |
| Investing Cash Flow | $-21,192 | $-17,862 | $1,129 | $2,970 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 54,792 | 24,369 | 2,280 | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | 300 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 6,250 | 0 |
| Financing Cash Flow | $54,792 | $24,369 | $2,280 | $6,550 | $N/A |
| Exchange Rate Effect | -150 | -237 | 64 | 10 | N/A |
| Beginning Cash Position | 5,892 | 11,851 | 16,814 | 14,070 | N/A |
| End Cash Position | 21,516 | 5,892 | 11,851 | 16,810 | N/A |
| Net Cash Flow | $15,624 | $-5,959 | $-4,963 | $2,740 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,826 | -12,229 | -8,436 | -6,790 | N/A |
| Capital Expenditure | -14 | -70 | -14 | N/A | N/A |
| Free Cash Flow | -17,840 | -12,299 | -8,450 | -6,790 | 0 |